A phase II study of IV gemcitabine (G) and oral capecitabine (C) in patients (pts) with advanced renal cell cancer (RCC): Results of Southwest Oncology Group study 0312
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: P. J. Van Veldhuizen, M. Hussey, P. N. Lara, P. H. Gumerlock, J. Clark, M. K. Lange, E. D. Crawford
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2265217099
